Abbott to Highlight Cancer Diagnostic Innovations at DDW 2026

Abbott will present six abstracts at the Digestive Disease Week (DDW) 2026, showcasing advancements in cancer diagnostics, particularly in colorectal, liver, and esophageal cancers. This includes the effectiveness of the Cologuard and Cologuard Plus tests, which are noninvasive options for colorectal cancer screening. The data emphasis underscores Abbott’s commitment to improving patient outcomes and addressing gaps in cancer detection.